{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T02:05:16Z","timestamp":1755223516221,"version":"3.43.0"},"reference-count":56,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Pancreas"],"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:sec>\n            <jats:title>Objectives<\/jats:title>\n            <jats:p>Early detection of cystic fibrosis (CF) related diabetes (CFRD) improves health outcomes and reduces CF-related mortality. The study aims to evaluate the ratio of islet amyloid polypeptide (IAPP) to C-peptide in CF patients with diabetes and without diabetes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Cross-sectional analysis was carried out in a prospective cohort of 33 participants (CF [n = 16] and CFRD [n = 18]). We examined the association of plasma IAPP:C-peptide ratio with clinical information, including glycated hemoglobin, and lung function markers.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The median (interquartile range) IAPP:C-peptide ratio was significantly (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.004) higher in people with CFRD (4.8 [4.5]) compared with participants without CFRD (12.1 [19.7]). The ratio of IAPP to C-peptide significantly accounted for a 38% variation in the diabetes status in patients with CF (<jats:italic toggle=\"yes\">r<\/jats:italic>\n                                 <jats:sup>2<\/jats:sup> = 0.399, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001). Islet amyloid polypeptide is strongly correlated with serum ferritin levels (<jats:italic toggle=\"yes\">r<\/jats:italic> = 0.683, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.005) and forced expiratory volume in CFRD, but not in nondiabetic participants with CF.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Islet amyloid polypeptide:C-peptide ratio could be a potential marker of CFRD in adults with CF. Further research requires validation of this marker in longitudinal cohort studies to confirm the capability of IAPP:C-peptide to predict CFRD.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mpa.0000000000002134","type":"journal-article","created":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T14:09:02Z","timestamp":1673014142000},"page":"1029-1036","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Association of Islet Amyloid Polypeptide to C-Peptide Ratio With Cystic Fibrosis\u2013Related Diabetes"],"prefix":"10.1097","volume":"51","author":[{"given":"Rohith N.","family":"Thota","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katie","family":"Wynne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shyamala","family":"Pradeepan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter A.B.","family":"Wark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manohar L.","family":"Garg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"bib1-20250811","first-page":"582","article-title":"Cystic fibrosis\u2013related diabetes: an update","volume":"9","year":"2022","journal-title":"QJM"},{"key":"bib2-20250811","doi-asserted-by":"crossref","first-page":"1179551419851770","DOI":"10.1177\/1179551419851770","article-title":"Cystic fibrosis\u2013related diabetes: pathophysiology and therapeutic challenges","volume":"12","year":"2019","journal-title":"Clin Med Insights Endocrinol Diabetes"},{"key":"bib3-20250811","doi-asserted-by":"crossref","first-page":"17421","DOI":"10.1038\/s41598-020-74502-1","article-title":"Lung function over the life course of paediatric and adult patients with cystic fibrosis from a large multi-centre registry","volume":"10","year":"2020","journal-title":"Sci Rep"},{"key":"bib4-20250811","doi-asserted-by":"crossref","first-page":"200293","DOI":"10.1183\/16000617.0293-2020","article-title":"Cystic fibrosis\u2013related diabetes and lung disease: an update","volume":"30","year":"2021","journal-title":"Eur Respir Rev"},{"key":"bib5-20250811","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1136\/adc.2010.208652","article-title":"Increased detection of cystic-fibrosis\u2013related diabetes in Australia","volume":"96","year":"2011","journal-title":"Arch Dis Child"},{"key":"bib6-20250811","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/resp.12227","article-title":"Australian standards of care for cystic fibrosis\u2013related diabetes","volume":"19","year":"2014","journal-title":"Respirology"},{"issue":"suppl 2","key":"bib7-20250811","first-page":"S3","article-title":"Cystic fibrosis related diabetes: pathophysiology, screening and diagnosis","volume":"18","year":"2019","journal-title":"J Cyst Fibros"},{"key":"bib8-20250811","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jcf.2013.02.008","article-title":"Update on cystic fibrosis\u2013related diabetes","volume":"12","year":"2013","journal-title":"J Cyst Fibros"},{"key":"bib9-20250811","doi-asserted-by":"crossref","first-page":"E1022","DOI":"10.1152\/ajpendo.2001.281.5.E1022","article-title":"Mechanisms of insulin resistance in cystic fibrosis","volume":"281","year":"2001","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"bib10-20250811","first-page":"1267","article-title":"Diabetes mellitus in cystic fibrosis is characterized by islet amyloidosis","volume":"81","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"bib11-20250811","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/BF00718598","article-title":"Cystic fibrosis associated islet changes may provide a basis for diabetes. An immunocytochemical and morphometrical study","volume":"414","year":"1989","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"bib12-20250811","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1651-2227.1993.tb12653.x","article-title":"Longitudinal evaluation of glucose tolerance and insulin secretion in non-diabetic children and adolescents with cystic fibrosis: results of a two-year follow-up","volume":"82","year":"1993","journal-title":"Acta Paediatr"},{"key":"bib13-20250811","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jpeds.2007.09.025","article-title":"Glucose tolerance and insulin secretion, morbidity, and death in patients with cystic fibrosis","volume":"152","year":"2008","journal-title":"J Pediatr"},{"key":"bib14-20250811","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.jcf.2015.02.009","article-title":"Insulin secretion abnormalities in exocrine pancreatic sufficient cystic fibrosis patients","volume":"14","year":"2015","journal-title":"J Cyst Fibros"},{"key":"bib15-20250811","doi-asserted-by":"crossref","first-page":"E200","DOI":"10.1152\/ajpendo.00333.2015","article-title":"CFTR silencing in pancreatic \u03b2-cells reveals a functional impact on glucose-stimulated insulin secretion and oxidative stress response","volume":"310","year":"2016","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"bib16-20250811","doi-asserted-by":"crossref","first-page":"823","DOI":"10.2337\/dc17-1387","article-title":"Islet interleukin-1\u03b2 immunoreactivity is an early feature of cystic fibrosis that may contribute to \u03b2-cell failure","volume":"41","year":"2018","journal-title":"Diabetes Care"},{"key":"bib17-20250811","doi-asserted-by":"crossref","first-page":"10356","DOI":"10.1038\/s41598-020-66602-9","article-title":"Amylin and beta amyloid proteins interact to form amorphous heterocomplexes with enhanced toxicity in neuronal cells","volume":"10","year":"2020","journal-title":"Sci Rep"},{"key":"bib18-20250811","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.bbamem.2018.02.020","article-title":"IAPP in type II diabetes: basic research on structure, molecular interactions, and disease mechanisms suggests potential intervention strategies","volume":"1860","year":"2018","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"bib19-20250811","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/BF00500385","article-title":"Plasma islet amyloid polypeptide (amylin) levels and their responses to oral glucose in type 2 (non-insulin-dependent) diabetic patients","volume":"34","year":"1991","journal-title":"Diabetologia"},{"key":"bib20-20250811","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jcf.2014.01.008","article-title":"The screening and diagnosis of cystic fibrosis\u2013related diabetes in the United Kingdom","volume":"13","year":"2014","journal-title":"J Cyst Fibros"},{"key":"bib21-20250811","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.2337\/dc10-1768","article-title":"Clinical care guidelines for cystic fibrosis\u2013related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society","volume":"33","year":"2010","journal-title":"Diabetes Care"},{"issue":"suppl 1","key":"bib22-20250811","first-page":"36","article-title":"Routine screening for cystic fibrosis\u2013related diabetes","volume":"102","year":"2009","journal-title":"J R Soc Med"},{"issue":"suppl 1","key":"bib23-20250811","first-page":"40","article-title":"Routine OGTT screening for CFRD\u2014no thanks","volume":"102","year":"2009","journal-title":"J R Soc Med"},{"key":"bib24-20250811","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1111\/pedi.12914","article-title":"Screening for cystic fibrosis\u2013related diabetes and prediabetes: evaluating 1,5-anhydroglucitol, fructosamine, glycated albumin, and hemoglobin A1c","volume":"20","year":"2019","journal-title":"Pediatr Diabetes"},{"key":"bib25-20250811","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1002\/ppul.22988","article-title":"Improved screening for cystic fibrosis\u2013related diabetes by an integrated care team using an algorithm","volume":"49","year":"2014","journal-title":"Pediatr Pulmonol"},{"key":"bib26-20250811","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1108\/IJHCQA-05-2014-0059","article-title":"Improving screening for diabetes in cystic fibrosis","volume":"28","year":"2015","journal-title":"Int J Health Care Qual Assur"},{"key":"bib27-20250811","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jcf.2016.02.005","article-title":"Glycated hemoglobin cannot yet be proposed as a screening tool for cystic fibrosis related diabetes","volume":"15","year":"2016","journal-title":"J Cyst Fibros"},{"key":"bib28-20250811","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1136\/jcp.200X.033944","article-title":"Best practice in primary care pathology: review 3","volume":"59","year":"2006","journal-title":"J Clin Pathol"},{"key":"bib29-20250811","first-page":"153","article-title":"Ferrokinetic and hematologic studies in cystic fibrosis patients","volume":"5","year":"1983","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"bib30-20250811","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.2337\/diacare.22.6.1008","article-title":"Potential impact of HbA1c determination on clinical decision making in patients with cystic fibrosis\u2013related diabetes","volume":"22","year":"1999","journal-title":"Diabetes Care"},{"key":"bib31-20250811","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1111\/dme.13912","article-title":"Association between HbA1c and the development of cystic fibrosis\u2013related diabetes","volume":"36","year":"2019","journal-title":"Diabet Med"},{"key":"bib32-20250811","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jpeds.2004.12.039","article-title":"Epidemiology of cystic fibrosis\u2013related diabetes","volume":"146","year":"2005","journal-title":"J Pediatr"},{"key":"bib33-20250811","doi-asserted-by":"crossref","first-page":"134","DOI":"10.2337\/db16-0394","article-title":"Reduced \u03b2-cell secretory capacity in pancreatic-insufficient, but not pancreatic-sufficient, cystic fibrosis despite normal glucose tolerance","volume":"66","year":"2017","journal-title":"Diabetes"},{"key":"bib34-20250811","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1530\/eje.1.01836","article-title":"Insulin-secretion abnormalities and clinical deterioration related to impaired glucose tolerance in cystic fibrosis","volume":"152","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"bib35-20250811","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jcf.2011.11.001","article-title":"Reduced levels of active GLP-1 in patients with cystic fibrosis with and without diabetes mellitus","volume":"11","year":"2012","journal-title":"J Cyst Fibros"},{"key":"bib36-20250811","first-page":"1257","article-title":"Amylin\/insulin secretory ratios in morbidly obese man: inverse relationship with glucose disappearance rate","volume":"78","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"bib37-20250811","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/BF00399099","article-title":"Effect of dexamethasone on insulin sensitivity, islet amyloid polypeptide and insulin secretion in humans","volume":"36","year":"1993","journal-title":"Diabetologia"},{"key":"bib38-20250811","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.2337\/diab.40.12.1615","article-title":"Decrease of stimulated amylin release precedes impairment of insulin secretion in type II diabetes","volume":"40","year":"1991","journal-title":"Diabetes"},{"key":"bib39-20250811","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s001250050092","article-title":"Role of islet amyloid polypeptide secretion in insulin-resistant humans","volume":"37","year":"1994","journal-title":"Diabetologia"},{"key":"bib40-20250811","first-page":"E903","article-title":"Distribution and kinetics of amylin in humans","volume":"274","year":"1998","journal-title":"Am J Physiol"},{"key":"bib41-20250811","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00006676-200104000-00013","article-title":"High glucose concentration favors the selective secretion of islet amyloid polypeptide through a constitutive secretory pathway in human pancreatic islets","volume":"22","year":"2001","journal-title":"Pancreas"},{"key":"bib42-20250811","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s001250051138","article-title":"Prolonged exposure of pancreatic beta cells to raised glucose concentrations results in increased cellular content of islet amyloid polypeptide precursors","volume":"42","year":"1999","journal-title":"Diabetologia"},{"key":"bib43-20250811","doi-asserted-by":"crossref","first-page":"17231","DOI":"10.1038\/s41598-017-17404-z","article-title":"Structural abnormalities in islets from very young children with cystic fibrosis may contribute to cystic fibrosis\u2013related diabetes","volume":"7","year":"2017","journal-title":"Sci Rep"},{"key":"bib44-20250811","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1210\/jc.2004-0405","article-title":"Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes","volume":"89","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"bib45-20250811","doi-asserted-by":"crossref","first-page":"G50","DOI":"10.1152\/ajpgi.00074.2016","article-title":"Relationship between pancreatic hormones and glucose metabolism: a cross-sectional study in patients after acute pancreatitis","volume":"311","year":"2016","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"bib46-20250811","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1385\/IJGC:31:1-3:123","article-title":"The specificity of amylin for the diagnosis of pancreatic adenocarcinoma","volume":"31","year":"2002","journal-title":"Int J Gastrointest Cancer"},{"key":"bib47-20250811","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/S0026-0495(97)90209-2","article-title":"Hyperamylinemia is associated with hyperinsulinemia in the glucose-tolerant, insulin-resistant offspring of two Mexican-American non-insulin-dependent diabetic parents","volume":"46","year":"1997","journal-title":"Metabolism"},{"key":"bib48-20250811","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1161\/CIRCRESAHA.111.258285","article-title":"Hyperamylinemia contributes to cardiac dysfunction in obesity and diabetes","volume":"110","year":"2012","journal-title":"Circ Res"},{"key":"bib49-20250811","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s001250050672","article-title":"Rat amylin mediates a pressor response in the anaesthetised rat: implications for the association between hypertension and diabetes mellitus","volume":"40","year":"1997","journal-title":"Diabetologia"},{"key":"bib50-20250811","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1161\/01.HYP.26.3.460","article-title":"Amylin stimulates plasma renin concentration in humans","volume":"26","year":"1995","journal-title":"Hypertension"},{"key":"bib51-20250811","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1097\/00004872-200018110-00012","article-title":"Circulating amylin in human essential hypertension: heritability and early increase in individuals at genetic risk","volume":"18","year":"2000","journal-title":"J Hypertens"},{"key":"bib52-20250811","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/BF02576242","article-title":"The stimulatory effect of amylin on mucus secretion in isolated rat trachea","volume":"193","year":"1993","journal-title":"Res Exp Med (Berl)"},{"key":"bib53-20250811","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/BF02576799","article-title":"Amylin immunoreactivity in the rat trachea and characterization of the interaction of amylin and somatostatin on airway mucus secretion","volume":"195","year":"1995","journal-title":"Res Exp Med (Berl)"},{"key":"bib54-20250811","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.cmet.2013.02.007","article-title":"Iron and diabetes risk","volume":"17","year":"2013","journal-title":"Cell Metab"},{"key":"bib55-20250811","doi-asserted-by":"crossref","first-page":"5226","DOI":"10.1021\/ic4001413","article-title":"Heme bound amylin: spectroscopic characterization, reactivity, and relevance to type 2 diabetes","volume":"52","year":"2013","journal-title":"Inorg Chem"},{"key":"bib56-20250811","first-page":"1873","article-title":"Causative factors for formation of toxic islet amyloid polypeptide oligomer in type 2 diabetes mellitus","volume":"10","year":"2015","journal-title":"Clin Interv Aging"}],"container-title":["Pancreas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPA.0000000000002134","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:03:17Z","timestamp":1754956997000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPA.0000000000002134"}},"subtitle":["A Prospective Cross-sectional Study"],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":56,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/mpa.0000000000002134","relation":{},"ISSN":["1536-4828","0885-3177"],"issn-type":[{"type":"electronic","value":"1536-4828"},{"type":"print","value":"0885-3177"}],"subject":[],"published":{"date-parts":[[2022,9]]}}}